University Of MissouriEcho Global Granger Management Mercy HealthFox Chase Cancer CenterEclipse VenturesMayo ClinicGe HealthcareAstra Zeneca
Description
Nucleus RadioPharma announced the closing of a Series A extension round with new investor AstraZeneca, joining existing investors GE Healthcare, Mayo Clinic, and others. The funding will be used to expand development, supply, and commercial manufacturing capabilities to make targeted radiotherapies and theranostics more accessible to patients globally.
Company Information
Company
Nucleus RadioPharma
Location
Davidson, North Carolina, United States
About
Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies. With an emphasis on innovation and quality, Nucleus provides an array of services, from formulation and analytical development to regulatory documentation and drug product manufacturing. Its technology platforms are at the forefront of radiopharmaceutical research, designed to advance new therapies through clinical trials to commercialization.
Don't miss Nucleus RadioPharma's next move
Get an email the moment Nucleus RadioPharma raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
1 contact
Predictive Intelligence
Strategic
ML-powered predictions for Nucleus RadioPharma's next move